• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.

作者信息

Bhalla Vikas, Georgiopoulou Vasiliki V, Azeem Ali A, Marti Catherine N, Cole Robert T, Laskar Sonjoy R, De Staercke Christine, Hooper W Craig, Smith Andrew L, Kalogeropoulos Andreas P, Butler Javed

出版信息

Int J Cardiol. 2011 Sep 1;151(2):237-9. doi: 10.1016/j.ijcard.2011.06.048. Epub 2011 Jul 1.

DOI:10.1016/j.ijcard.2011.06.048
PMID:21723628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3988491/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7a/3988491/58893f9ad47c/nihms-566856-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7a/3988491/58893f9ad47c/nihms-566856-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a7a/3988491/58893f9ad47c/nihms-566856-f0001.jpg

相似文献

1
Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.基质金属蛋白酶、金属蛋白酶组织抑制剂与心力衰竭结局
Int J Cardiol. 2011 Sep 1;151(2):237-9. doi: 10.1016/j.ijcard.2011.06.048. Epub 2011 Jul 1.
2
Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.组织金属蛋白酶抑制剂（TIMPs）与心力衰竭。
Heart Fail Rev. 2012 Sep;17(4-5):693-706. doi: 10.1007/s10741-011-9266-y.
3
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.基质金属蛋白酶和金属蛋白酶组织抑制剂在左心室舒张功能障碍和射血分数保留心力衰竭的细胞外基质重塑中的作用：系统评价和荟萃分析。
Int J Mol Sci. 2020 Sep 14;21(18):6742. doi: 10.3390/ijms21186742.
4
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats.在高血压大鼠从肥大向心力衰竭转变过程中，基质金属蛋白酶的过度激活与左心室重塑同时发生。
J Am Coll Cardiol. 2002 Apr 17;39(8):1384-91. doi: 10.1016/s0735-1097(02)01756-4.
5
Ventricular remodeling and function: insights using murine echocardiography.心室重构和功能：使用小鼠超声心动图获得的见解。
J Mol Cell Cardiol. 2010 Mar;48(3):512-7. doi: 10.1016/j.yjmcc.2009.07.004. Epub 2009 Jul 15.
6
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.TIMPs 与心脏重构：“拥抱 MMP 家族的非依赖性一面”。
J Mol Cell Cardiol. 2010 Mar;48(3):445-53. doi: 10.1016/j.yjmcc.2009.09.013. Epub 2009 Sep 30.
7
Matrix metallopropteinases in heart failure.心肌衰竭中的基质金属蛋白酶。
Curr Top Med Chem. 2012;12(10):1181-91. doi: 10.2174/1568026611208011181.
8
Invited commentary.特邀评论。
Ann Thorac Surg. 2008 Oct;86(4):1249. doi: 10.1016/j.athoracsur.2008.07.041.
9
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.心力衰竭进展过程中压力超负荷的人类心肌中的基质金属蛋白酶及其组织抑制剂
J Am Coll Cardiol. 2004 Oct 19;44(8):1609-18. doi: 10.1016/j.jacc.2004.07.023.
10
Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.伴有和不伴有心室扩张的心力衰竭中基质金属蛋白酶的差异激活
Cardiovasc Res. 2003 Mar;57(3):766-74. doi: 10.1016/s0008-6363(02)00792-7.

引用本文的文献

1
Inflammation markers associated with symptoms and neighborhood deprivation in black adults with heart failure.与心力衰竭黑人成年人的症状及社区贫困相关的炎症标志物
Heart Lung. 2025 Jul 9;74:121-128. doi: 10.1016/j.hrtlng.2025.07.001.
2
Extracellular matrix-mediated cellular communication in the heart.心脏中细胞外基质介导的细胞通讯
J Mol Cell Cardiol. 2016 Feb;91:228-37. doi: 10.1016/j.yjmcc.2016.01.011. Epub 2016 Jan 14.
3
Biomarkers and mortality in severe Chagas cardiomyopathy.严重查加斯心肌病中的生物标志物与死亡率

本文引用的文献

1
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.金属蛋白酶组织抑制剂（TIMPs）：一个具有结构和功能多样性的古老家族。
Biochim Biophys Acta. 2010 Jan;1803(1):55-71. doi: 10.1016/j.bbamcr.2010.01.003. Epub 2010 Jan 15.
2
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.《2010年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2010 Feb 23;121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667. Epub 2009 Dec 17.
3
Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers.
Glob Heart. 2015 Sep;10(3):173-80. doi: 10.1016/j.gheart.2015.07.003.
4
Clinical adoption of prognostic biomarkers: the case for heart failure.临床采用预后生物标志物：心力衰竭案例。
Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):3-13. doi: 10.1016/j.pcad.2012.05.004.
急性心力衰竭综合征发作与肌钙蛋白和细胞外基质标志物水平升高有关。
Circ Heart Fail. 2010 Jan;3(1):44-50. doi: 10.1161/CIRCHEARTFAILURE.108.844324. Epub 2009 Oct 22.
4
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure.细胞外基质周转和炎症标志物可独立预测慢性心力衰竭的功能状态和预后。
J Card Fail. 2008 Aug;14(6):467-74. doi: 10.1016/j.cardfail.2008.02.014. Epub 2008 May 27.
5
Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality.慢性心力衰竭患者金属蛋白酶组织抑制剂水平：死亡率的独立预测指标
Eur J Heart Fail. 2008 Apr;10(4):388-95. doi: 10.1016/j.ejheart.2008.02.015. Epub 2008 Mar 17.
6
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.心肌基质重塑与基质金属蛋白酶：对心脏形态和功能的影响。
Physiol Rev. 2007 Oct;87(4):1285-342. doi: 10.1152/physrev.00012.2007.
7
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.基质金属蛋白酶-1及其抑制剂TIMP-1在收缩性心力衰竭中的作用：与功能数据及预后的关系
J Intern Med. 2007 Sep;262(3):385-92. doi: 10.1111/j.1365-2796.2007.01823.x.
8
Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.通过连续的健康状况评估来识别近期心血管事件高风险的心力衰竭患者。
Circulation. 2007 Apr 17;115(15):1975-81. doi: 10.1161/CIRCULATIONAHA.106.670901. Epub 2007 Apr 9.
9
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.血管紧张素转换酶抑制剂对基质金属蛋白酶活性的抑制作用可预防心力衰竭大鼠模型的左心室重构。
Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3057-64. doi: 10.1152/ajpheart.00447.2006. Epub 2007 Feb 16.
10
Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.2005年美国心脏病学会/美国心脏协会慢性心力衰竭治疗指南中的药物治疗建议。
Ann Pharmacother. 2006 Sep;40(9):1607-17. doi: 10.1345/aph.1H059. Epub 2006 Aug 8.